Fig. 2From: The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysisOverall survival with (blue) or without (red) neoadjuvant immunotherapy for (a) all patients with only neoadjuvant therapies; b patients who received neoadjuvant chemotherapy; c patients who received neoadjuvant chemoradiationBack to article page